首页期刊导航|中华地方病学杂志
期刊信息/Journal information
中华地方病学杂志
中国疾病预防控制中心地方病控制中心
中华地方病学杂志

中国疾病预防控制中心地方病控制中心

孙殿军

双月刊

2095-4255

cje2005@163.com

0451-86675924

150081

黑龙江省哈尔滨市南岗区保健路157号

中华地方病学杂志/Journal Chinese Journal of EndemiologyCSCD北大核心CSTPCD
查看更多>>中华医学会、哈尔滨医科大学主办。本刊主要报道克山病、大骨节病、碘缺乏病、地方性氟、砷中毒、鼠疫、布鲁杆菌病、寄生虫等疾病的研究成果。主要栏目:述评、综述、专家论坛、论著、现场调查、临床医学、检测方法、卫生管理、学术争鸣、防治经验等。《中国地方病学杂志》被美国《化学文摘》、荷兰《医学文摘》、美国《剑桥科学文摘》和波兰《哥伯尼索引》收录;是中国自然科学、中国生物医学核心期刊,预防医学、卫生学类核心期刊。2008年获中华医学会优秀期刊二等奖,2010年获中华医学会优秀期刊奖。
正式出版
收录年代

    全国地方病防治机构氟化物检测实验室外质控考核结果分析

    纪晓红王伟赵丽军高琳...
    141-147页
    查看更多>>摘要:目的 分析2006 - 2023年全国地方病防治机构氟化物检测实验室外质控考核情况,掌握全国各省、市、县级地方病防治机构氟化物检测实验室氟检测外质控能力,确保全国地方性氟中毒监测数据的准确性和可靠性。 方法 采用回顾性分析,对2006 - 2023年,所有全国地方病防治机构氟化物检测实验室外质控考核结果进行汇总分析。其中2006 - 2008年的考核结果,采用Grubbs法检验异常值;Cochran法检验方差齐性,剔除不合格实验室的考核数据,计算总平均值和总标准差;Z比分法检验实验室考核情况,采用│Z│ < 3的结果进行统计和判定。2009 - 2023年的考核结果来自所有实验室,其中2010年按上、下半年进行两次,其余年份每年1次。采用稳健统计,分别计算各实验室的Z比分数,当│Z│≤2时,考核结果为合格;当2 <│Z│ < 3时,考核结果为基本合格;当│Z│≥3时,考核结果为不合格,公议值来自所有参加考核的实验室。 结果 从2006年质控运行之初到2023年,参加外质控考核的实验室数量明显增加。其中参加水氟考核的实验室由2006年的30个增加到2023年的1 277个,参加尿氟考核的实验室由29个增加到497个;参加砖茶氟考核的实验室由2014年的43个增加到2023年的193个。考核结果显示,当│Z│ < 3时,全国地方病防治机构氟化物检测实验室水氟外质控总合格率为95.2%,其中最低是2008年为87.1%(27/31)最高是2014年为100.0%(394/394);当│Z│≤2时,总的反馈合格率为88.4%,其中2010年上半年最低,为79.3%(288/363),2014年最高,为99.5%(392/394)。考核结果显示,当│Z│ < 3时,全国地方病防治机构氟化物检测实验室尿氟外质控总合格率为98.0%,其中2006、2007年最低,均为86.2%(25/29),是2014年最高,为100.0%(68/68);当│Z│≤2时,总合格率为93.7%,其中最低是2010年下半年为86.5%(64/74),最高是2014年为100%(68/68)。考核结果显示,当│Z│ < 3时,全国地方病防治机构氟化物检测实验室砖茶氟外质控总合格率为95.4%,其中最低是2023年为85.0%(164/193),2014、2015、2016年最高,为100.0%(43/43、51/51、79/79);当│Z│≤2时,总合格率为89.2%,其中2017年最低,为72.7%(32/44),2014年最高,为100.0%(43/43)。2009 - 2023年水氟检测考核全部合格的省级实验室共21个,其中市、县级实验室全部合格的省份共3个;尿氟检测考核全部合格的省级实验室共11个,其中市、县级实验室全部合格的省份仅1个;2014 - 2023年茶氟检测考核全部合格的省级实验室共5个,无市、县级实验室全部合格的省份。 结论 2006 - 2023年,参加外质控考核的氟化物检测实验室数量逐年增加,大部分省、市、县级实验室均具有较好的氟化物检测能力,能够满足地方病防治监测的检测需求;对于部分存在问题的实验室,要有针对性地进行整改,提高检测质量,以期为地方性氟中毒病区监测工作提供更好的技术保障。 Objective To analyze the external quality control assessment results of fluoride testing laboratories in endemic disease prevention and control institutions nationwide from 2006 to 2023, investigate the quality control capabilities of these laboratories in various provinces, prefectures, cities, and counties nationwide, and ensure the accuracy and reliability of surveillance data on endemic fluorosis nationwide. Methods Using retrospective analysis, the external quality control assessment results of all participating fluoride testing laboratories of national endemic disease prevention and control institutions from 2006 to 2023 were summarized and analyzed. The assessment results from 2006 to 2008 were tested for outliers using Grubbs method, homogeneity of variance using Cochran method, excluding the assessment data of unqualified laboratories, calculating the total mean and total standard deviation, Z-score method was used to test the assessment of laboratories, and statistical analysis and judgment were done when the result of │Z│ < 3. The assessment results from 2009 - 2023 were obtained from all laboratories. In 2010, two tests were conducted in the first and second half of the year, and the Z-ratio scores of each laboratory were calculated using robust statistics. When │Z│≤2, the assessment was qualified when 2 < │Z│ < 3, the assessment was basically qualified when│Z│≥3, the assessment was unqualified, and the consensus value came from all participating laboratories in the assessment. Results From the beginning of quality control operation in 2006 to 2023, the number of laboratories participated in external quality control assessments had significantly increased. The number of laboratories participated in water fluoride assessment increased from 30 in 2006 to 1 277 in 2023, and the number of laboratories participated in urine fluoride assessment increased from 29 to 497. The number of laboratories participated in the brick tea fluorine assessment had increased from 43 in 2014 to 193 in 2023. The assessment results showed that when │Z│ < 3, the total qualified rate of fluoride external quality control in fluoride testing laboratories of national endemic disease control institutions was 95.2%, with the lowest being 87.1% (27/31) in 2008 and the highest being 100.0% (394/394) in 2014. When │Z│≤2, the total feedback pass rate was 88.4%, with the lowest being 79.3% (288/363) in the first half of 2010 and the highest being 99.5% (392/394) in 2014. The assessment results showed that when │Z│ < 3, the total pass rate of urine fluoride external quality control in fluoride testing laboratories of national endemic disease control institutions was 98.0%, with the lowest being 86.2% (25/29) in 2006 and 2007, respectively, and the highest being 100.0% (68/68) in 2014. When │Z│≤2, the total qualification rate was 93.7%, with the lowest being 86.5% (64/74) in the second half of 2010 and the highest being 100.0% (68/68) in 2014. The assessment results showed that when│Z│ < 3, the total pass rate of extra-fluoride quality control of brick tea in fluoride testing laboratories of national endemic disease control institutions was 95.4%, with the lowest being 85.0% (164/193) in 2023, and the highest being 100.0% (43/43, 51/51, 79/79) in 2014, 2015 and 2016, respectively. When │Z│≤2, the total pass rate was 89.2%, with the lowest being 72.7% (32/44) in 2017 and the highest being 100.0% (43/43) in 2014. From 2009 to 2023, there were a total of 21 provincial-level laboratories that passed the water fluoride detection assessment, including 3 provinces where all prefecture level and county-level laboratories were qualified. The assessment results of urinary fluorine showed that there were 11 qualified provincial-level laboratories and 1 prefecture-level laboratory. From 2014 to 2023, the assessment results of brick-tea fluorine showed that there were 5 provincial-level laboratories that passed the tea fluorine testing assessment and no prefecture-level laboratory. Conclusions Conclusion: From 2006 to 2023, the number of fluoride testing laboratories participating in external quality control assessment has increased year by year, and most provincial, municipal and county-level laboratories have good fluoride testing capabilities, which can meet the testing needs of endemic disease prevention and monitoring. For some laboratories with problems, targeted rectification should be carried out to improve the quality of detection, in order to provide better technical support for the monitoring of endemic fluorosis areas.

    地方病实验室质控考核回顾分析

    青海省54例男性布鲁氏菌病患者血清IL-6检测结果分析

    陈阳阳李强王建玲李积权...
    148-149页
    查看更多>>摘要:布鲁氏菌病简称布病,是一种由布鲁氏菌属细菌引起的人畜共患传染性疾病,主要通过直接或间接接触染疫动物、食用被病原体污染的肉类或乳制品等途径而感染[1]。布病在甲乙类法定传染病中发病率排第8位,是少数仍保持上升趋势的传染病之一[2]。目前,布病仍然危害着我国畜牧业发展、人类健康和公共卫生安全。白细胞介素-6(interleukin-6,IL-6)作为一种辅助型T细胞2(T helper 2 cell,Th2)细胞因子,不仅参与炎症反应过程,还调节代谢、再生等多种生物过程[3]。本研究通过对青海省54例男性布病患者进行血清IL-6含量检测,观察男性布病患者炎性改变情况,为制定布病防治策略提供科学依据。

    布鲁氏菌病血清白细胞介素-6

    青海省囊谦县土壤、饮用水微量元素含量检测结果分析

    周昕王明君沈洪婷李强...
    150-151页
    查看更多>>摘要:囊谦县位于青海省最南端,总面积为12 741 km2,总人口为13万人,其中藏族人口占99%以上,以牧业为主体经济;域内有金、银、铜、铁、铅、锌、锡、石膏、硫磺、石灰石、煤、盐等矿产资源,属于环境严重缺碘地区[1]。同时,囊谦县也是地方性氟中毒流行区。

    饮用水土壤微量元素

    人间布鲁氏菌病的治疗策略

    戴立波丁海涛杨宏昕李文妍...
    152-156页
    查看更多>>摘要:布鲁氏菌病(布病)是由布鲁氏菌感染引起的人畜共患传染病,迄今为止动物间布病尚未根除,且缺乏安全有效的人体疫苗,因此,"早期、联合、足量、足疗程"的药物治疗仍然是人间布病管理中的重要策略。布病治疗目标为缓解和缩短症状期,减少并发症,防止复发以及转为慢性等。目前,尽管抗感染治疗对于大部分患者效果良好,但仍有一部分患者发生治疗失败或后期复发等情况,因此,布病的治疗策略亟待优化。本文阐述了布病治疗原则、临床治疗现状及未来发展趋势,以期为优化布病药物治疗方法提供参考。 Brucellosis is a zoonotic infectious disease caused by Brucella infection. So far, animal to animal Brucellosis has not been eradicated, and there is a lack of safe and effective human vaccine. Therefore, "early, combined, sufficient, and full course" drug treatment remains an important strategy in the management of human Brucellosis. The goal of treating brucellosis is to alleviate and shorten the symptom period, reduce complications, relapses, and chronicity. At present, although antibiotic treatment is effective for most patients, there are still some patients who experience treatment failure or later recurrence, so the treatment strategy for brucellosis urgently needs to be optimized. This article elaborates on the treatment principles, clinical treatment status, and future development trends of brucellosis, in order to provide references for optimizing drug treatment methods for brucellosis.

    布鲁氏菌病抗感染治疗策略抗菌药物

    线粒体生物发生关键调控因子PGC-1α在砷致神经系统损伤中作用机制的研究进展

    马欣博刘晓娜杨艳梅吴师菲...
    157-160页
    查看更多>>摘要:砷作为一种可影响人类健康的毒性物质,过量时可引发包括认知障碍在内的多种神经功能障碍。相关流行病学调查和动物实验研究均显示,砷暴露不仅可以使人出现智力障碍,引发外周神经病变,还会使人群及动物行为出现异常。目前,砷致神经系统损伤的机制仍不明确。过氧化物酶体增殖物激活受体γ辅助活化因子α(PGC-1α)作为一种核转录辅助激活因子,能与转录因子或其他辅助激活因子相互作用,在线粒体生物发生、能量代谢等生物学过程中发挥作用。PGC-1α通过激活线粒体生物发生影响能量代谢,激活氧化应激调节因子[过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)等]影响氧化应激等方式,减轻砷对中枢神经系统、周围神经系统及血脑屏障(BBB)的损伤。本文总结了砷致神经系统损伤及PGC-1α在砷致神经系统损伤中作用机制的研究进展,为进一步防治因砷所致的神经系统疾病提供理论依据。 Arsenic, as a toxic substance that can affect human health, can cause various neurological disorders, including cognitive impairment, when excessive. Relevant epidemiological surveys and animal experimental studies have shown that exposure to arsenic can not only cause intellectual impairment and peripheral neuropathy in humans, but also lead to abnormal behavior in humans and animals. However, so far, the mechanism of arsenic induced damage to the nervous system is still unclear. Peroxisome proliferator activated receptor γ auxiliary activation factor 1α (PGC-1α), as a nuclear transcription coactivator, can interact with transcription factors or other coactivators and plays a role in biological processes such as mitochondrial biogenesis and energy metabolism. PGC-1α, by activating mitochondrial biogenesis, affecting energy metabolism, activating oxidative stress regulatory factors [catalase (CAT), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), etc.], mitigates the damage to the central nervous system (CNS), peripheral nervous system (PNS), and blood-brain barrier (BBB) caused by arsenic. This article summarize the research progress of arsenic-induced neurological injury and the mechanism of PGC-1α's role in arsenic-induced neurological injury to provide a theoretical basis for further prevention and treatment of neurological diseases caused by arsenic.

    神经毒性过氧化物酶体增殖物激活受体γ辅助活化因子α神经系统

    氟化物对骨髓间充质干细胞影响的研究进展

    吴雨航李喜功潘文明张钦...
    161-164页
    查看更多>>摘要:氟是自然界广泛存在的一种重要元素,适量摄入可预防龋齿、促进骨骼发育。但长期过量摄入,可引发氟中毒,损害牙齿、骨骼、心肌、血管等组织或器官。骨髓间充质干细胞(BMSCs)凭借自身多向的分化潜能特性在骨损伤的修复过程中发挥着重要作用。因此,研究BMSCs对治疗因氟中毒所致的氟骨症具有重要意义。本文总结了氟化物对BMSCs影响及作用机制的研究进展,为氟骨症发病机制研究和临床治疗提供新的思路。 Fluorine is an important element widely present in nature, and moderate intake can prevent dental caries and promote bone development. However, long-term excessive intake can lead to fluorosis, damaging tissues or organs such as teeth, bones, heart muscle, and blood vessels. Bone marrow mesenchymal stem cells (BMSCs) play an important role in the repair process of bone injury due to their excellent multi-directional differentiation potential. Therefore, studying BMSCs is of great value in the treatment of fluorosis caused by fluoride poisoning. This article summarize the progress on the effect of fluoride on BMSCs, providing new ideas for the study of the pathogenesis and clinical treatment of fluorosis.

    氟化物骨髓间充质干细胞成骨分化细胞凋亡

    不同临床阶段的大骨节病中西医治疗的研究进展

    骞童寇久社郭雄周静...
    165-172页
    查看更多>>摘要:大骨节病(Kashin-Beck disease,KBD)是一种地方性、多发性、对称性、变形性骨关节病,好发于发育期儿童的骨骺生长板和关节软骨,可致软骨细胞变性、降解和坏死,临床上依据患者病变范围和畸形程度分为早期、Ⅰ度、Ⅱ度和Ⅲ度4个阶段。KBD的病因与发病机制至今仍不清楚,针对此病尚无特效药,对各种医学干预手段有效性的研究也较少。目前,KBD的治疗多参照中西医关于骨关节炎的相关方法。本文以现有研究作为基础,依据KBD的疾病分期对其中西医治疗方法进行了总结分析,提出应在阶梯化和个体化原则下,中西医并重治疗,并以药物治疗为主、手术治疗为辅,最大程度减轻患者疼痛、保护关节和预防损伤,以期为临床治疗KBD提供参考依据。 Kashin-Beck disease (KBD) is an endemic, multiple, symmetrical and deformable osteoarthropathy that is more common in the epiphysis growth plate and articular cartilage of developing children and can cause degeneration, degradation and necrosis of chondrocyte. Clinically, it is divided into four stages based on the extent of the patient's lesion and degree of deformity: early stage, gradeⅠ, gradeⅡ and gradeⅢ. The etiology and pathogenesis of KBD are still unclear, there is no specific drug for this disease. There is also limited study on the effectiveness of various medical interventions. Currently, the treatment of KBD mostly refers to the relevant methods of traditional Chinese and Western medicine for osteoarthritis. This article is based on the existing study, and summarizes and analyzes the Chinese and Western medicine treatment methods for KBD based on the disease staging. It is proposed that both Chinese and Western medicine should be treated under the principles of ladder and individualization, with drug therapy as the main treatment and surgical treatment as the auxiliary treatment, so as to minimize patient pain, protect joints and prevent injuries, and provide reference for clinical treatment of KBD.

    大骨节病地方病阶梯化治疗双醋瑞因青藤碱